Three scenarios, three stress factors, and the sensitivity analysis that shows why commercial mix is not optional for Scenario C. Built from R6 v1.1 corrected multiples and B5 SBIR D2P2 valuation lift data.
Ch 6 names the hill-selection failure mode: "Each product carries the full burden. Two products don't cost twice as much; they cost more, because context-switching, divided attention, and competing priorities create operational friction." The valuation thesis fails the same way when it is not stress-tested. The scenarios below are not projections. They are decision tools. The question is: under which conditions does the thesis hold, and under which conditions does it collapse?
| Comparable | Type | EV/Revenue (v1.1 corrected) | ARR / Revenue | Relevance to NorthAI |
|---|---|---|---|---|
| Palantir (PLTR) | Public · classified integrator | 108x (FY2024 annual $2.866B, EV $309.85B) | $2.866B | Aspirational ceiling. Classified integrations + 25-year DoD relationships + commercial segment justify the premium. Not achievable without classified program wins and commercial scale. |
| Govini | Private · unclassified defense strategy | 10x (Oct 2025, $100M ARR, $1.0B valuation) | $100M | Realistic Scenario C ceiling. Govini competes in the same unclassified defense-intelligence analytics space. 10x at $100M ARR is the credible target for NorthAI if it reaches scale without classified positioning. |
| BigBear.ai (BBAI) | Public · defense AI analytics | 13.5x (current, down from 23.2x; EV $1.77B, TTM $132M) | $132M | Market-repricing signal. 42% EV decline with flat revenue shows pure federal-AI platforms face multiple compression. NorthAI cannot use 23x as a comparable; 13.5x is the current honest reference. |
| Vannevar Labs | Private · defense AI decision support | 7.2x (Series B, $575M on $80M revenue) | $80M | Scenario B target. Pre-classified, defense AI analytics. Similar positioning to NorthAI Year 1-2 target. 7.2x at $80M ARR. |
| Booz Allen Hamilton (BAH) | Public · pure services integrator | 1.54x (FY2025 baseline; current ~1.30x) | $12B | Services floor. Where NorthAI's valuation anchors if productization does not happen. Scenario A ceiling. |
| Anduril Industries | Private · defense autonomy | 29x (Series H May 2026, $61B, $2.1B revenue) | $2.1B | Context only. Weaponized autonomy + Arsenal production ($2.2B → $4.3B revenue projection) justifies the premium. Not a NorthAI comparable, different risk profile, different scale, hardware manufacturing component. |
BigBear.ai's 42% EV collapse shows that markets can reprice defense-AI platforms rapidly when growth expectations are not met. The repricing happened with flat revenue ($132M). The cause: multiple compression driven by competitive pressure and investor rotation out of pure-federal positioning.
The stress question for NorthAI's Scenario C: if the federal-AI multiple band compresses from 6-8x to 4-6x during NorthAI's Series A/B raise window (2027-2028), what happens to the valuation thesis?
If BBAI repricing spreads to all federal-AI platforms, Scenario C multiple compresses. Pure-federal positioning depresses to 4-5x. Lower end if customer concentration peaks (top 3 agencies = 60%+ revenue).
Govini-comparable positioning. Federal-focused SaaS with ATO achieved and 15-20 customers. Dual market thesis partially demonstrated. ConMon costs covered at current scale.
Commercial defense prime integrators (Northrop, Raytheon, L3Harris) as paying customers alongside federal agencies. Defense BD product line generating recurring revenue from commercial channel. 20-40% premium over pure-federal positioning.
FedRAMP Moderate ConMon (continuous monitoring) costs $200-500K annually. LI-SaaS ConMon is lower ($50-100K/year) but still perpetual. Ch 7 is explicit: "ConMon costs are required indefinitely. Annual assessments, scanning, POA&M management are real costs." The stress test: if ConMon costs land at the high end ($400-500K/year for Moderate) and NorthAI reaches authorization before reaching sufficient ARR to cover the cost sustainably, the business model is inverted.
At $500K ConMon + $500K support + $600K ops = $1.6M fixed base. At 60% gross margin, NorthAI needs $2.7M ARR just to cover costs. At 50 customers averaging $60K ARR each (250 users at $240/user/year), that is covered at $3M ARR. The math works at scale; it does not work at 5-10 customers. The path to scale (three paying customers per Ch 6's validation threshold, then expand) is the only way to avoid an inverted ConMon cost structure. Investors who understand federal will ask this question directly.
Federal AI spending reached $7.2B in FY2026 obligations (up 966% YoY per federal budget data). That growth rate assumes appropriated budgets move on schedule. Continuing resolutions (CRs) freeze agency spending at prior-year levels and prevent new contract starts. DOGE-era spending scrutiny adds the risk of program termination.
| Scenario | Revenue Impact on NorthAI | Multiple Impact | Mitigation |
|---|---|---|---|
| CR extends 3-6 months (no new starts) | Delays first contract award. Pipeline freezes. No new obligated revenue during CR window. | No impact on existing ARR; delays Scenario B ARR ramp by 3-6 months | CHN-direct commercial customers (defense prime integrators) are not subject to federal CRs. Commercial mix is the structural hedge. |
| OUSD R&E budget cut 20% (program restructure) | If OSI&A or adjacent programs are restructured, near-term OUSD R&E customer base shrinks. High concentration risk if OUSD R&E is the primary initial market. | Moderate: concentration risk compresses multiple if top 2-3 customers are at risk | Diversify agency footprint beyond OUSD R&E early. Target DIA, INSCOM, AFRL as parallel customers in first 18 months. |
| SBIR Phase II D2P2 program paused or defunded | Eliminates the fastest path from AFWERX STTR to direct commercialization funding. No impact on privately-funded productization path. | Moderate: delays SBIR-funded Phase II, which was the low-cost path to first federal-SaaS revenue | Productized services path does not depend on D2P2 funding. Two revenue paths are safer than one. |
The X2 cross-stream reconciliation finding is direct: "Scenario C requires dual federal/commercial for greater than 8x per X2 finding." The sensitivity analysis quantifies the effect:
| Commercial Revenue Mix | Federal Revenue Mix | Multiple Band | Pre-Money at $30M ARR | Evidence |
|---|---|---|---|---|
| 0% (pure federal) | 100% | 4-6x (compressed) | $120-180M | BBAI repricing signal (23.2x → 13.5x). Pure federal platforms under compression pressure. |
| 10-20% (early commercial) | 80-90% | 6-8x (base) | $180-240M | Govini positioning (federal-primary, defense-prime commercial adjacency). 10x at $100M ARR. |
| 30-40% (meaningful commercial) | 60-70% | 8-10x (premium) | $240-300M | Anduril's dual-market positioning (DoD + commercial autonomy). Federal + commercial optionality commands investor premium. |
| 50%+ (dual market) | 50% | 10-15x (aspirational) | $300-450M | BigBear.ai pre-compression at 23.2x had significant commercial analytics positioning. Requires demonstrated commercial channel (not just pipeline). |
Defense BD product line is the commercial-mix lever. If Defense BD gains traction with Northrop Grumman, Raytheon, or L3Harris as direct customers (defense prime integrators using NorthAI analytics for their own competitive intelligence and R&D strategy), that revenue stream is non-federal. It lifts the multiple without additional authorization costs.